The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

A few years ago, the small lab Valisure generated headlines after purportedly finding astronomical levels of the cancer-causing chemical NDMA in Zantac (ranitidine).

Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims The executive, a medical doctor who oversaw drug safety for decades at drugmaker GSK, repeatedly ...

First-ever trial over Zantac cancer claims gets underway in Cook County The lawsuit is one of many claims made nationwide that the over-the-counter heartburn drug Zantac and its generics have an ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.

The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months.

Several big drugmakers will not have to face thousands of lawsuits claiming Zantac can cause cancer after a federal judge ruled there was not enough scientific evidence to support those claims.

Zantac cancer trial results in hung jury A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.